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Uroporphyrinogen oxidation by hepatic microsomes from chick embryos or mice pretreated with methylcholanthrene 
was increased by addition of iron-EDTA. This increase was partially prevented by catalase, mannitol, ketoconazole and 
piperonyl butoxide, whereas only ketoconazole and piperonyl butoxide inhibited the oxidation in the presence and ab- 
sence of iron-EDTA. These data suggest that the oxidations of uroporphyrinogen in the presence and absence of added 
iron occur by different mechanisms. 
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1. iNTRODUCTION 
The uroporphyria caused by polyhalogenated 
hydrocarbons i  similar to the human disease, por- 
phyria cutanea tarda (PCT) in its clinical and 
biochemical manifestations [1,2]. Both conditions 
are characterized by massive hepatic accumulation 
of 7 and 8 carboxyl porphyrins [1,2]. Uropor- 
phyrinogen is rapidly oxidized to uroporphyrin by 
hepatic microsomes from chick embryos, rats and 
mice pretreated with methylcholanthrene (MC) 
[3,4,6]. This observation has led to the hypothesis 
that uroporphyrinogen oxidation is mediated by a 
specific cytochrome P-450 isozyrne, P450IA2, 
which directly or indirectly has a major role in 
chemically induced uroporphyria [3-6]. 
Iron has been implicated in both experimental 
uroporphyria and clinical PCT, but its role is 
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unknown [2]. Several investigators have described 
chemical systems in which iron plus hydrogen 
peroxide cause uroporphyrinogen oxidation, pro- 
bably due to hydroxyl radical formation [5,7,8]. 
De Matteis found that iron-EDTA accelerates 
uroporphyrinogen oxidation by microsomes from 
fl-naphthoflavone-induced chick embryo liver in 
the presence of 3,4,3' ,4'-tetrachlorobiphenyl 
(TCB) and NADPH [7,8]. This observation sug- 
gests that in microsomes, reactive oxygen derived 
from uncoupled cytochrome P-450 electron 
transport interacts with an endogenous iron pool 
to cause porphyrinogen oxidation [7,8]. The pur- 
pose of the present study was to determine if 
uroporphyrinogen oxidation by cytochrome P-450 
and the iron-mediated increase in the rate of this 
oxidation occur by the same mechanism. 
2. EXPERIMENTAL  
Catalase (thymol-free), superoxide ismutase, ketoconazole, 
MC and mannitol were purchased from Sigma (St. Louis, MO); 
uroporphyrin I from Porphyrin Products (Logan, UT); desfer- 
rioxamine (DFX) from Ciba-Geigy (Summit, NJ); piperonyl 
butoxide (PIP) and TCB from Ultra-Science (Hope, RI); 
dimethyl sulfoxide (DMSO) from Fluka (Hauppauge, NY) and 
Imferon (iron dextran) from Merrill-Dow (Cincinnati, OH). 
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Animals, treatments and preparation of microsomal fractions 
are described in [6], except hat, where indicated, Imferon was 
given to mice at a dose of 12.5 mg iron/mouse, 72 h prior to 
treatment with MC. The oxidation of uroporphyrinogen to 
uroporphyrin was followed fluorometrically as in [6]. Iron- 
EDTA was prepared by mixing 0.1 M EDTA with an equal 
volume of 0.05 M ferric chloride. PIP and TCB were added as 
solutions in DMSO, and the concentration of DMSO in the 
assay never exceeded 250 mM. Ketoconazole was dissolved in 
50% acetone. 
Preliminary experiments using chick embryo microsomes 
tested whether the buffer (0.05 M Hepes, pH 7.6) or the 
chelating agent (1 mM EDTA) used routinely in these studies 
affected uroporphyrinogen oxidation. Since Hepes participates 
in free radical reactions [9], liver microsomes from MC-induced 
chick embryos were also prepared using Mes (0.05 M, pH 7.6) 
as buffer. Neither Hepes nor Mes affected the oxidation rates. 
Iron-EDTA promotes hydroxyl radical formation, but desfer- 
rioxamine iron chelates do not [10]. Hepatic microsomes from 
chick embryos induced with MC were isolated in the presence 
of 1 mM DFX or 1 mM EDTA and were assayed fo r uropor- 
phyrinogen oxidation as described in table 1 except that the buf- 
fer contained DFX, EDTA, or no chelator. The rate of 
uroporphyrinogen oxidation was not affected by the chelating 
agent used for preparation of the microsomes or present in the 
assay. 
3. RESULTS 
3.1. Chick embryo liver microsomes 
In the presence of TCB, iron-EDTA markedly 
stimulated uroporphyrinogen oxidation by hepatic 
microsomes i olated from MC-treated chick em- 
bryos (table 1) as previously shown for hepatic 
microsomes from ~-naphthoflavone-treated em- 
bryos [7]. In the absence of TCB, the oxidation 
was much slower, but it was also stimulated by 
iron (table 1). 
To ascertain if reactive oxygen species were in- 
volved in the iron stimulation, the effects of 
catalase and mannitol on uroporphyrinogen oxida- 
tion were examined. Catalase addition to the assay 
inhibited the stimulatory effect of iron-EDTA, but 
had no effect on uroporphyrinogen oxidation in 
the absence of added iron (table 1). Mannitol, a 
hydroxyl radical scavenger, also markedly in- 
hibited iron stimulation, but had no effect on 
uroporphyrinogen oxidation in the absence of add- 
ed iron (fig.l). 
We also examined the effect of cytochrome 
P-450 inhibitors on the iron-EDTA stimulation of 
uroporphyrinogen oxidation, since previously we 
demonstrated that uroporphyrinogen oxidation, in 
the absence of added iron, is catalyzed by a 
specific, MC-induced isozyme of cytochrome 
Table 1 
Effect of iron-EDTA on uroporphyrinogen oxidation by 
hepatic microsomes from chick embryos treated with MC 
Addition to assay Uroporphyrinogen oxidation 
(pmol/min per mg protein) 
No Fe-EDTA Fe-EDTA 
(50/zM) 
None 6.6 _+ 0.0 31.9 + 1.8 
Cataiase 6.6 + 0.0 17.7 + 1.9 
TCB 40.9 + 4.0 74.0 + 10.0 
TCB + catalase 40.8 + 4.7 51.3 + 4.0 
Oxidation of uroporphyrinogen to uroporphyrin was followed 
at room temperature spectrofluorometricaily. The assay 
mixture contained 1ml assay buffer (0.25 M sucrose, 0.05 M 
Hepes, 1 mM EDTA; pH 7.6), 0.01 ml microsomai suspension 
containing 0.15-0.2 mg protein, 0.02 ml NADPH-generating 
system [6]. Uroporphyrinogen I was reduced with sodium 
amalgam [6] and used at a final concentration of 2/zM. The 
reaction was started by the addition of 0.01 ml TCB (0.2 mg/ml 
solution in DMSO). Iron-EDTA was used at a final 
concentration of 50/zM Fe. Catalase was used at 0.03 mg/ml 
(greater quantities of catalase did not increase the inhibitory 
effect). Data from a representative experiment are shown 
(mean _ SD of triplicate assays). In 6 separate xperiments, 
catalase inhibited the iron-EDTA stimulation of microsomal 
uroporphyrinogen oxidation from 40 to 90% 
P-450 [3,6]. The cytochrome P-450 inhibitors, 
ketoconazole [12] and PIP [13], almost completely 
prevented uroporphyrinogen oxidation by MC- 
induced chick embryo liver microsomes, both with 
and without added iron-EDTA (fig.2A,B). These 
results uggest that uroporphyrinogen oxidation is 
cytochrome P-450 dependent, in the presence as 
well as the absence of added iron. 
3.2. Mouse liver microsomes 
Table 2 shows that iron-EDTA increased 
uroporphyrinogen oxidation by hepatic micro- 
somes from mice treated with MC or corn oil. This 
increase was prevented by catalase and superoxide 
dismutase. In an experiment analogous to the one 
with chick embryo liver microsomes, mannitol did 
not affect uroporphyrinogen oxidation by micro- 
somes from an MC-induced mouse, but almost 
completely prevented the stimulation by iron- 
EDTA (not shown). At 10/~M, PIP inhibited 
uroporphyrinogen oxidation by microsomes from 
an MC-induced mouse by 67%; in the presence of 
iron-EDTA, the inhibition was 63%. 
Experiments with iron administered to mice in 
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Fig.1. Effect of mannitol on iron-EDTA stimulation of 
uroporphyrinogen oxidation by liver microsomes from MC- 
induced chick embryos. Assay conditions are described in table 
1. (©) Activity in the presence of TCB; (o) activity in the 
presence of 50/zM iron-EDTA and TCB. Data are presented as 
means and ranges of 2 assays for each data point. 
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Fig.2. Effect of ketoconazole (A) and piperonyl butoxide (B) on 
iron-EDTA stimulation of uroporphyrinogen oxidation by liver 
microsmes from MC-induced chick embryos. Chick embryo 
treatment and microsome preparation are described in [6]. The 
assay is described in table 1. (o) Activity in the presence of 
TCB; (o) activity in the presence of 50/LM iron-EDTA and 
TCB. Data are presented as means and ranges of 2 assays for 
each data point. The assay mixture was incubated with PIP at 
room temperature for 10 min before TCB and 
uroporphyrinogen were added to allow formation of the 
P-450-PIP complex. 
Table 2 
Effect of catalase and superoxide dismutase on iron-EDTA 
stimulation of uroporphyrinogen oxidation by mouse liver 
microsomes 
Treatment Addition 
to assay 
Uroporphyrinogen oxidation 
(pmol/min per mg protein) 
No Fe-EDTA Fe-EDTA 
(50 .uM) 
Corn oil 
MC 
none 7.5 (7.0-8.0) 29.0 (21.0-37.0) 
catalase 6.6 (6.6-6.6) 13.3 (13.3-13.3) 
SOD 6.2 (6.2-6.2) 12.3 (12.3-12.3) 
none 35.0 (33.3-36.4) 53.0 (51.5-54.5) 
catalase 33.3 (33.3-33.3) 37.5 (36.4-42.0) 
SOD 32.0 (30.3-33.3) 35.7 (35.7-35.7) 
catalase + 
SOD 30.6 (27.8-33.3) 35.7 (35.7-35.7) 
Treatments and assay conditions are described in [6] and table 
1, except that in rodents, TCB is not needed to start he reaction 
[6]. Catalase was used at 0.03 mg/ml (greater quantitites of 
catalase did not increase the inhibitory effect). Superoxide 
dismutase was used at 114 U/ml. Results are expressed as 
means and ranges for 2 or more assays for each addition 
vivo were conducted to see if excess iron present in 
the liver would increase uroporphyr inogen oxida- 
t ion in vitro. Pr ior to treatment with MC,  the mice 
were treated with Imferon to increase liver stores 
of  iron [14]. The iron status of  the animal had no 
effect on the rate of  uroporphyr inogen oxidat ion 
either by hepatic microsomes or 10000 x g super- 
natants f rom corn oil or MC-treated animals (not 
shown). These results indicate that the excess iron 
present in the isolated microsomes is not 
equivalent to i ron -EDTA added to the assay. 
4. D ISCUSSION 
De Matteis proposed that cytochrome 
P-450-catalysed uroporphyr inogen oxidation re- 
quires reactive oxygen species and non-heme iron 
[7,8]. This raises the question of  whether uropor-  
phyr inogen oxidation, in the presence or absence 
of  added iron, occurs by the same mechanism. 
However ,  our results suggest that uropor-  
phyr inogen is oxidized by different mechanisms in 
the presence or absence o f  added iron. The iron- 
EDTA stimulation of  microsomal  uropor-  
phyr inogen oxidat ion involved reactive oxygen 
species, since it was inhibited by catalase and man- 
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nitol. In the absence of  added iron, microsomal 
uroporphyr inogen oxidation was not inhibited by 
catalase, mannitol,  or superoxide dismutase, 
which indicates that reactive oxygen species were 
probably not responsible for this reaction. I f  such 
species were involved, the reaction may have oc- 
curred within the hydrophobic membrane where it 
would be inaccessible to catalase and mannitol, as 
has been suggested for metal-dependent lipid 
peroxidation [15]. 
The inhibitory effects of  ketoconazole and P IP  
imply that uroporphyr inogen oxidation, both in 
the presence and absence of  added iron, is depen- 
dent on cytochrome P-450. The mechanism by 
which cytochrome P-450 oxidizes uropor- 
phyrinogen is unknown, but we have no evidence 
that endogenous iron is required for the reaction 
catalysed by the specific, MC-induced cytochrome 
P-450, since the chelators, DFX and EDTA,  had 
no effect on the reaction. Furthermore, uropor- 
phyrinogen oxidation was not increased in 
microsomes from iron-loaded mice. Cytochrome 
P-450 may produce some reactive oxygen species 
required for stimulation of  uroporphyr inogen ox- 
idation by added iron [7,8]. The reactive oxygen 
species involved in iron-stimulated uropor- 
phyrinogen oxidation may be hydroxyl radical, 
which may also be generated by the interaction of  
i ron-EDTA with NADPH-cytochrome P-450 
reductase [16,17]. 
Our data do not explain the role of  iron in 
uroporphyria.  One possible role is to increase d;- 
aminolevulinic acid synthetase [18], which would 
increase the liver concentration of  uropor- 
phyrinogen. Products of  uroporphyr inogen oxida- 
tion may inhibit uroporphyr inogen decarboxylase 
[4-6,19]. Thus the role of  iron in vivo may be to 
increase the concentration of  uroporphyr inogen 
and hence, the inhibitory products. Furthermore, 
the results presented here suggest hat the addition 
o f  i ron-EDTA to microsomes may not be an ap- 
propriate model for the events that lead to uropor- 
phyria. 
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